Beeler Brian K 4
4 · Horizon Therapeutics Public Ltd Co · Filed Aug 17, 2021
Insider Transaction Report
Form 4
Beeler Brian K
EVP, General Counsel
Transactions
- Sale
Ordinary Shares
2021-08-16$106.00/sh−74,898$7,939,188→ 90,918 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-16−65,857→ 0 totalExercise: $22.14Exp: 2025-03-22→ Ordinary Shares (65,857 underlying) - Exercise/Conversion
Ordinary Shares
2021-08-16$22.14/sh+65,857$1,458,074→ 165,816 total
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.6312 to $106.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.